The United States will lend Kodak $765 million to make drug components

The pandemic has revealed the extent to which domestic companies rely on foreign suppliers, which may be risky in industries like pharmaceuticals, said IT, Analytics and Operations Kaitlin Wowak in a New York Times article.

Published

Related News & Stories

All News & Stories